A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

BACKGROUND: Docetaxel plus cisplatin and 5-fluorouracil has become a new standard for treating advanced gastric cancer. However, high rates of severe neutropenia limit its application. Modification of the regimen could be the solution to get similar activity but less myelosuppression. METHODS: Patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Li, C-P, Chen, J-S, Chen, L-T, Yen, C-J, Lee, K-D, Su, W-P, Lin, P-C, Lu, C-H, Tsai, H-J, Chao, Y
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2010
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2990611/
https://ncbi.nlm.nih.gov/pubmed/20924378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605928
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados